Log in

Relevant bibliographies by topics / Min jian gu shi / Journal articles

To see the other types of publications on this topic, follow the link: Min jian gu shi.

Journal articles on the topic 'Min jian gu shi'

Author: Grafiati

Published: 4 June 2021

Last updated: 27 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 31 journal articles for your research on the topic 'Min jian gu shi.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Liu, Hao−Lan, Tengfei Zhu, Xinyi Wen, et al. "Chemical and Microbial Differences of Root and Rhizosphere Soil among Different Provenances of Fokienia hodginsii." Forests 15, no. 6 (2024): 1005. http://dx.doi.org/10.3390/f15061005.

Full text

Abstract:

Aims: Fokienia hodginsii is a threatened conifer tree species, known as the dominant nursery-grown species capable of colonizing the challenging woodland environments in southern China due to its strong root penetrating ability. The ecological phenotype of Fokienia hodginsii is not well documented during its breeding process, which limits the potential planting area and its ecological function. This study aims to understand how Fokienia hodginsii associates with microbes to conduct its key ecological function and provide a theoretical basis for further improving the forest nursery management o

APA, Harvard, Vancouver, ISO, and other styles

2

Li, Jian-An, Ming-Peng Shi, Lin Cong, et al. "Erratum to "A Tale of Two Setae: How Morphology and ITS2 Help Delimit a Cryptic Species Complex in Eulophidae (Hymenoptera: Chalcidoidea)"." Insect Systematics and Diversity 3, no. 5 (2019): 1. https://doi.org/10.1093/isd/ixz021.

Full text

Abstract:

Li, Jian-An, Shi, Ming-Peng, Cong, Lin, Gu, Ming-Yu, Chen, Yi-Heng, Wang, Si-Yi, Li, Zhen-Hua, Zan, Chun-Fang, Wei, Wan-Fu (2019): Erratum to "A Tale of Two Setae: How Morphology and ITS2 Help Delimit a Cryptic Species Complex in Eulophidae (Hymenoptera: Chalcidoidea)". Insect Systematics and Diversity (AIFB) 3 (5), No. 10: 1-1, DOI: 10.1093/isd/ixz021, URL: http://dx.doi.org/10.4103/1673-5374.353504

APA, Harvard, Vancouver, ISO, and other styles

3

Wang, Jian, Shi-Shi Lin, Jun-Shen Gan, et al. "A new species of the genus Boulenophrys from South China (Anura, Megophryidae)." Zootaxa 5514, no. 5 (2024): 451–68. https://doi.org/10.11646/zootaxa.5514.5.3.

Full text

Abstract:

Wang, Jian, Lin, Shi-Shi, Gan, Jun-Shen, Chen, Hong-Hui, Yu, Ling-Min, Pan, Zhong, Xiao, Jia-Jie, Zeng, Zhao-Chi (2024): A new species of the genus Boulenophrys from South China (Anura, Megophryidae). Zootaxa 5514 (5): 451-468, DOI: 10.11646/zootaxa.5514.5.3, URL: http://dx.doi.org/10.11646/zootaxa.5514.5.3

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Huaping, Guantie Deng, Tatjana Došenović, and Nawab Hussain. "Note on recent common coupled fixed point results in multiplicative metric spaces." Applied Mathematics and Nonlinear Sciences 3, no. 2 (2019): 659–68. http://dx.doi.org/10.2478/amns.2018.2.00050.

Full text

Abstract:

AbstractThe purpose of this paper is to improve and complement the main results of Jiang and Gu (J. Nonlinear Sci. Appl., 10 (2017), 1881–1895). By using nontrivial methods, some common coupled fixed point results in metric spaces are obtained. Moreover, it is shown that some recent fixed point results in the setting of multiplicative metric spaces are actually equivalent to the counterpart of the standard metric spaces. In addition, an example to illustrate the presented theoretical result is also given.

APA, Harvard, Vancouver, ISO, and other styles

5

Alaufey, Rayan, and Maureen H. Tang. "A Mechanistic Investigation of Electrochemical Ozone Production Using Nickel and Antimony Doped Tin Oxide in Non-Aqueous Electrolytes." ECS Meeting Abstracts MA2022-02, no. 64 (2022): 2389. http://dx.doi.org/10.1149/ma2022-02642389mtgabs.

Full text

Abstract:

Electrochemical water splitting to produce hydrogen has attracted great interest as an environmentally-friendly renewable fuel. While cathodic hydrogen evolution (HER) is a relatively fast process that produces a valuable chemical, the anodic oxygen evolution reaction (OER) is a slow process that adds little to no economic value to water splitting.1,2 Generating a high-performance oxidizer such as ozone instead of oxygen could make water splitting more economically feasible because of the added value of ozone. However, electrochemical ozone production (EOP) catalysts are typically hindered by

APA, Harvard, Vancouver, ISO, and other styles

6

Lin, Yuehe, and Dan (Annie) Du. "(Invited) New Bioinspired Nanomaterials for Biosensing and Cancer Theranostics." ECS Meeting Abstracts MA2022-01, no. 53 (2022): 2202. http://dx.doi.org/10.1149/ma2022-01532202mtgabs.

Full text

Abstract:

Nature is an excellent source of inspiration for the widespread application of science and technology. Researchers learn from biological principles and gradually develop from the earliest direct use of biological materials to the design and development of new biomimetic materials inspired by nature. Therefore, the innovation of bioinspired nanomaterials will enable tremendous advances in biology and biochemistry with biomimetic capabilities, such as biosensing, cell imaging, and drug delivery. In this presentation, I will discuss my group’s recent work on two bioinspired nanomaterials: nano-pe

APA, Harvard, Vancouver, ISO, and other styles

7

Yu, Ruihan, Lifeng Wang, Yanqiu Ma, et al. "Addition of NaCl or Sucrose on the Protein Content, and Functional and Physicochemical Properties of Egg Whites Liquid under Heat Treatment." Foods 12, no. 4 (2023): 881. http://dx.doi.org/10.3390/foods12040881.

Full text

Abstract:

In this study, differences in the protein content and functional and physicochemical properties of four varieties of egg white (EW) were studied by adding 4–10% sucrose or NaCl and then heating them at 70 °C for 3 min. According to a high-performance liquid chromatography (HPLC) analysis, the percentages of ovalbumin, lysozyme and ovotransferrin rose with an increase in the NaCl or sucrose concentration; however, the percentages of ovomucin and ovomucoid decreased. Furthermore, the foaming properties, gel properties, particle size, α-helixes, β-sheets, sulfhydryl groups and disulfide bond cont

APA, Harvard, Vancouver, ISO, and other styles

8

Wen, Dongqing, Lei Tu, Guiyou Wang, Zhao Gu, Weiru Shi, and Xiaopeng Liu. "Psychophysiological Responses of Pilots in Hypoxia Training at 7000 and 7500 m." Aerospace Medicine and Human Performance 91, no. 10 (2020): 785–89. http://dx.doi.org/10.3357/amhp.5634.2020.

Full text

Abstract:

INTRODUCTION: We compared the physiological responses, psychomotor performances, and hypoxia symptoms between 7000 m and 7500 m (23,000 and 24,600 ft) exposure to develop a safer hypoxia training protocol.METHODS: In altitude chamber, 66 male pilots were exposed to 7000 and 7500 m. Heart rate and arterial oxygen saturation were continuously monitored. Psychomotor performance was assessed using the computational task. The hypoxic symptoms were investigated by a questionnaire.RESULTS: The mean duration time of hypoxia was 323.0 56.5 s at 7000 m and 218.2 63.3 s at 7500 m. The 6-min hypoxia train

APA, Harvard, Vancouver, ISO, and other styles

9

Hamilton, Erika, Jian Zhang, Liming Liu, et al. "Abstract CT247: A Phase 1/2a, multicenter, open-label, non-randomized first-in-human study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of DB-1303 in patients with advanced/metastatic solid tumors." Cancer Research 83, no. 8_Supplement (2023): CT247. http://dx.doi.org/10.1158/1538-7445.am2023-ct247.

Full text

Abstract:

Abstract Background: Epidermal growth factor receptor 2 (EGFR2 or HER2) has shown gene amplification/over-expression in more than 30% of all human cancers, including breast cancer, gastric, colon, salivary gland, bladder, and uterine serous carcinoma, and its overexpression in tumors is associated with poor prognosis. DB-1303 (developed by DUALITYBIO INC.) is an antibody-drug conjugate (ADC) comprised of a humanized anti-HER2 IgG1 monoclonal antibody (BAT0606), covalently linked to a proprietary DNA topoisomerase I inhibitor (P1003) via a cleavable linker containing maleimide tetrapeptide (GGF

APA, Harvard, Vancouver, ISO, and other styles

10

Hu, Jia, Jun Ni, Longxian Jiao, et al. "Abstract 6321: HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models." Cancer Research 83, no. 7_Supplement (2023): 6321. http://dx.doi.org/10.1158/1538-7445.am2023-6321.

Full text

Abstract:

Abstract Background: Fibroblast growth factors (FGFs) and their receptors (FGFRs) regulate numerous cellular processes. Dysregulation of FGFR signaling due to receptor fusion, mutation or amplification is observed across multiple cancer types, making activated FGFRs an important therapeutic target. Herein, we present the preclinical characterization of HMPL-453, a highly potent and selective inhibitor of FGFR1, 2, and 3, discovered and being currently developed in phase II clinical trial (NCT04353375) by HUTCHMED. Methods: Kinase activity was measured by Transcreener™ Fluorescence Polarization

APA, Harvard, Vancouver, ISO, and other styles

11

Yang, Na, Jia Hu, Tingwen Li, et al. "Abstract 543: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2." Cancer Research 83, no. 7_Supplement (2023): 543. http://dx.doi.org/10.1158/1538-7445.am2023-543.

Full text

Abstract:

Abstract Background: Mutations in isocitrate dehydrogenase (IDH) 1/2 are frequently identified in various cancers, such as AML, cholangiocarcinoma, chondrosarcoma and glioma. Mutant IDHs (mIDHs) cause accumulated 2-HG, leading to blockage of cell differentiation, thereby inducing malignant transformation. Rare cases were identified carrying co-existing mutations in IDH1 and IDH2. mIDH isoform switching, from mutant IDH1 to mutant IDH2 and vice versa, have been reported as a mechanism of acquired resistance to IDH inhibition in AML and cholangiocarcinoma. Thus, simultaneous inhibition on both m

APA, Harvard, Vancouver, ISO, and other styles

12

Rui, Peng. "Concert activities of Chinese pianists: the history of development." Problems of Interaction Between Arts, Pedagogy and the Theory and Practice of Education 71, no. 71 (2024): 67–91. http://dx.doi.org/10.34064/khnum1-71.04.

Full text

Abstract:

Statement of the problem. The article discusses the formation and development of concert activities of Chinese pianists, starting from the 20th century. The performance art of Chinese pianists, although recognized today as an extremely bright phenomenon, is still the least studied among all areas of music art in the country. Objectives, methods, and novelty of the research. Analysis of the current musicological studies shows that, despite a significant number of the works devoted to the piano music of China and the performance creativity of Chinese pianists, the formation of latter’s concert a

APA, Harvard, Vancouver, ISO, and other styles

13

Jia, Guochong, Jie Ping, Ran Tao, et al. "Abstract 2286: Integrating multi-ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci." Cancer Research 85, no. 8_Supplement_1 (2025): 2286. https://doi.org/10.1158/1538-7445.am2025-2286.

Full text

Abstract:

Abstract Genome-wide association studies (GWAS) have identified more than 200 risk loci for breast cancer. However, target genes and their encoded proteins in these loci remain largely unknown. In this study, we utilized genetic prediction models for 1, 350 circulating proteins derived from individuals of African (n= 1, 871) and European (n= 7, 213) ancestry to investigate genetically predicted protein levels in association with breast cancer risk among females of African (n=40, 138), Asian (n= 137, 677), and European (n=247, 173) ancestry. We identified 70 blood protein biomarkers associated

APA, Harvard, Vancouver, ISO, and other styles

14

Liu, Ziqi, Min Hwan Lee, and ThomasJae Garcia. "3D Metal-Organic Framework Based Layered Double Hydroxide Core Shell Structure for Enhanced Oxygen Evolution Reaction." ECS Meeting Abstracts MA2022-02, no. 44 (2022): 1684. http://dx.doi.org/10.1149/ma2022-02441684mtgabs.

Full text

Abstract:

Electrochemical water splitting, an effective approach of generating high purity hydrogen in a clean way, is composed of two half reactions: hydrogen evolution reaction (HER) and oxygen evolution reaction (OER).[1] OER is the main rate-limiting half reaction for water splitting due to its sluggish four-electron transfer process.[2] , [3] An efficient electrocatalyst is indispensable to minimize the activation barrier for the reaction and achieve a high efficiency. Recently, two-dimensional (2D) layered double hydroxides (LDHs) have shown promises as one of the most effective electrocatalysts t

APA, Harvard, Vancouver, ISO, and other styles

15

Min, Byeongkwi, Lily Shi, Hye Jin Kim, et al. "Abstract 2634: AMB302/GR1017, an antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor shows therapeutic potency in orthotopic glioblastoma PDX and bladder cancer models with FGFR3-TACC3 fusion." Cancer Research 83, no. 7_Supplement (2023): 2634. http://dx.doi.org/10.1158/1538-7445.am2023-2634.

Full text

Abstract:

Abstract Background: FGFR3-TACC3 (F3-T3) fusion leads to FGFR3 kinase activation constitutively and acts as a driver mutation in several solid tumors. AMB302/GR1017 is a novel FGFR3 targeting ADC that was developed using the intelligent Ligase-Dependent Conjugation (iLDC) technologies from GeneQuantum (GQ) that provide high homogeneity, excellent druggability and high linker stability, and contains a topoisomerase 1 inhibitor as a payload. Based on the preclinical characterization, AMB302/GR1017 shows impressive anti-tumor activities against glioblastoma (GBM) and bladder cancer (BC) models wi

APA, Harvard, Vancouver, ISO, and other styles

16

Wu, C. Y., Q. Wang, J. Shi, et al. "AB0455 BARICITINIB IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS IN CHINA: 24-WEEK RESULTS OF POST-MARKETING SAFETY STUDY." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1418. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2148.

Full text

Abstract:

BackgroundBaricitinib, an orally selective inhibitor of JAK1 and JAK2, was approved for adult patients with moderate-to-severe rheumatoid arthritis (RA) in China. The recommended dose is 2mg once daily and 4mg once daily in patients who have inadequately responded to baricitinib 2mg once daily (for 3 months) or TNF inhibitors. A single-arm, prospective, non-interventional post-marketing safety study (PMSS) was conducted in Chinese RA patients to describe the safety and effectiveness of baricitinib at 24 weeks.ObjectivesTo describe the safety and effectiveness of baricitinib in real-world setti

APA, Harvard, Vancouver, ISO, and other styles

17

Lu, Shun, Ziming Li, Yan Wang, et al. "Abstract CT009: SHR-A1811, a HER2-directed antibody-drug conjugate (ADC), in advanced HER2-mutant non-small cell lung cancer (NSCLC): Updated phase 2 results from HORIZON-Lung." Cancer Research 85, no. 8_Supplement_2 (2025): CT009. https://doi.org/10.1158/1538-7445.am2025-ct009.

Full text

Abstract:

Abstract Background: SHR-A1811 is a novel ADC consisting of a humanized HER2-directed monoclonal antibody, cleavable tetrapeptide-based linker, and DNA topoisomerase I inhibitor. We conducted a multicenter, open-label, phase 1/2 study to evaluate SHR-A1811 in HER2-altered NSCLC. In the registrational phase 2 portion in patients (pts) with HER2-mutant NSCLC, the primary endpoint of IRC-assessed ORR was met (DCO, Jun. 14, 2024). Here, we presented an updated analysis after an additional 6-mo follow-up, focusing on survival outcomes. Methods: Pts with advanced NSCLC and centrally confirmed HER2 m

APA, Harvard, Vancouver, ISO, and other styles

18

Cai, Congcong, Shiya Zhu, Chunlin Chen, et al. "Abstract 1756: A fully characterized KIF18A inhibitor with superior potency and good druggability ready for IND application." Cancer Research 85, no. 8_Supplement_1 (2025): 1756. https://doi.org/10.1158/1538-7445.am2025-1756.

Full text

Abstract:

About ∼90% of the solid tumors and ∼75% of the hematologic malignancies are aneuploidy. The process that gives rise to aneuploidy is chromosomal instability (CIN), characterized by chromosome mis-segregation and other mitotic aberrations. KIF18A (kinesin family member 18A), part of the kinesin family of motor proteins, is expressed in the G2/M phase of the cell cycle and regulates chromosome positioning during cell division. Genetic depletion of KIF18A impacts the chromosome alignment, elongation of mitotic spindles, and traps chromosomally unstable tumor cells in mitosis, while having negligi

APA, Harvard, Vancouver, ISO, and other styles

19

Lu, Shun, Yongfeng Yu, Jianya Zhou, et al. "Abstract CT034: Phase II study of SCC244 in NSCLC patients harboring MET exon 14 skipping (METex14) mutations (GLORY study)." Cancer Research 82, no. 12_Supplement (2022): CT034. http://dx.doi.org/10.1158/1538-7445.am2022-ct034.

Full text

Abstract:

Abstract Background: METex14 mutations was reported in 3~4% of NSCLC patients and became a new target in the treatment of NSCLC. SCC244 is a highly selective and potent oral MET inhibitor. This is the first report of data from an ongoing single-arm phase II study of SCC244 in NSCLC patients with METex14 mutations (GLORY study). Methods: GLORY study is an open label, international, multi-center, single-arm phase II study to evaluate the efficacy and safety of SCC244 in patients with locally advanced or metastatic NSCLC harboring METex14 mutations which was confirmed by central laboratory. The e

APA, Harvard, Vancouver, ISO, and other styles

20

Zhou, Huixing, Long Chang, Jing Jia, et al. "Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study." Blood 142, Supplement 1 (2023): 4754. http://dx.doi.org/10.1182/blood-2023-180736.

Full text

Abstract:

Background Renal impairment (RI) is one of the cardinal features of newly diagnosed multiple myeloma (NDMM), contributing to dismal outcomes and high risk of early death. Improved renal function is associated with prolonged survival for NDMM. The triplet combination of pomalidomide with bortezomib and dexamethasone (PVD) has been proven to be effective in MM patients with RI [1] (The manuscript in preparation). However, the best renal overall response rate (ORR) was 78.8% and 21.2% of patients had no renal response to PVD. Here we reported an interim analysis to evaluate the renal and hematolo

APA, Harvard, Vancouver, ISO, and other styles

21

Hu, Jia, Jun Ni, Zhihu Gao, et al. "Abstract A094: Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor." Molecular Cancer Therapeutics 22, no. 12_Supplement (2023): A094. http://dx.doi.org/10.1158/1535-7163.targ-23-a094.

Full text

Abstract:

Abstract Background: Oncogenic activation of the RAS/MAPK signaling pathway is one of the leading causes for driving a variety of cancers. Src homology 2-containing protein tyrosine phosphatase 2 (SHP2) functions downstream of multiple RTKs, and integrates growth factor signals to promote RAS activation, making it an attractive drug target for cancers harboring oncogenic alterations in RAS/MAPK pathway. Herein, we present the preclinical characterization of HMPL-415, a highly potent, selective and non-competitive SHP2 inhibitor, discovered and being currently developed in phase I clinical tria

APA, Harvard, Vancouver, ISO, and other styles

22

Zhou, Huixing, Long Chang, Jie Ma, et al. "Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: Preliminary Analysis from a Phase 2, Prospective, Multicenter Study." Blood 144, Supplement 1 (2024): 1978. https://doi.org/10.1182/blood-2024-201978.

Full text

Abstract:

Background Newly diagnosed multiple myeloma (NDMM) patients have a high prevalence of renal impairment (RI). There is a need to identify effective and less toxicity therapeutic regimens. The triplet combination of pomalidomide with bortezomib and dexamethasone (PVD) has been proven to be effective in such entity [1]. However, the renal overall response rate (ORR) was 78.8% and 21.2% of patients had no renal response. There is still a critical need to improve renal function in severe RI population. Selinexor is an oral selective inhibitor of nuclear export compound, which specifically blocks ex

APA, Harvard, Vancouver, ISO, and other styles

23

Cheng, Ying, Xiqin Zhang, Lin Wu, et al. "Abstract CT126: Aumolertinib as adjuvant therapy in patients with stage II-IIIB EGFR-mutated NSCLC after complete tumor resection: A randomized, double-blind, placebo-controlled, phase 3 trial (ARTS)." Cancer Research 85, no. 8_Supplement_2 (2025): CT126. https://doi.org/10.1158/1538-7445.am2025-ct126.

Full text

Abstract:

Abstract Background: Lung cancer is the primary cause of cancer-related morbidity and mortality globally. Approximately 30% of patients with EGFR mutation (EGFRm) in NSCLC are diagnosed at an early stage and are candidates for curative-intent surgical resection; however, disease recurrence remains a substantial clinical challenge. Aumolertinib is a third-generation EGFR TKI that potently inhibits both sensitizing EGFR mutations (ex19del/L858R) and the resistance mutation T790M. ARTS (NCT04687241) is a randomized, double-blind, placebo-controlled, multicenter, phase 3 trial designed to evaluate

APA, Harvard, Vancouver, ISO, and other styles

24

Zhang, Qingyuan, Huiping Li, Yongmei Yin, et al. "Abstract PS14-03: Updated analyses from a Phase I study of the brain-penetrant oral SERD- SIM0270 in patients with ER-positive,HER2-negative advanced breast cancer." Clinical Cancer Research 31, no. 12_Supplement (2025): PS14–03—PS14–03. https://doi.org/10.1158/1557-3265.sabcs24-ps14-03.

Full text

Abstract:

Abstract Background: This is a phase I, multi-cohort, open label study of SIM0270 in patients with ER+/HER2- advanced breast cancer and the dose escalation part of phase Ia examined SIM0270 as monotherapy has been presented previously1. Here we present data from patients in the dose expansion part (Cohort S1)of SIM0270 monotherapy at the recommended dose (60mg PO QD) of phase Ia. Methods: In Cohort S1, SIM0270 was administered orally once daily in patients with ER+/HER2- locally advanced/metastatic breast cancer who had received ≥1 prior endocrine therapy(secondary endocrine resistant) and the

APA, Harvard, Vancouver, ISO, and other styles

25

Yao, Herui, Min Yan, Zhongsheng Tong, et al. "Abstract CT175: Safety, tolerability, pharmacokinetics, and antitumor activity of SHR-A1811 in HER2-expressing/mutated advanced solid tumors: A global phase 1, multi-center, first-in-human study." Cancer Research 83, no. 8_Supplement (2023): CT175. http://dx.doi.org/10.1158/1538-7445.am2023-ct175.

Full text

Abstract:

Abstract Background: SHR-A1811 is an ADC comprised of a humanized anti-HER2 monoclonal antibody (trastuzumab), a cleavable linker, and a DNA topoisomerase I inhibitor payload. Here we assessed SHR-A1811 in HER2-expressing/mutated unresectable, advanced, or metastatic solid tumors. Methods: Pts were eligible if they had HER2 positive breast cancer (BC), HER2 positive gastric/GEJ carcinoma, HER2 low-expressing BC, HER2-expressing/mutated NSCLC, or other HER2-expressing/mutated solid tumors, and were refractory or intolerant to standard therapy. SHR-A1811 at doses of 1.0-8.0 mg/kg was given Q3W (

APA, Harvard, Vancouver, ISO, and other styles

26

Wu, Jiong, Jian Zhang, Qingyuan Zhang, et al. "Abstract PS15-01: A first-in-human phase 1 study of SIM0270, a brain-penetrant oral selective estrogen receptor degrader (SERD), in patients with ER+/HER2- locally advanced or metastatic breast cancer." Cancer Research 84, no. 9_Supplement (2024): PS15–01—PS15–01. http://dx.doi.org/10.1158/1538-7445.sabcs23-ps15-01.

Full text

Abstract:

Abstract Background: ER+/HER2- breast cancer is the most prevalent subtype, and endocrine-based therapy is the standard treatment. SIM0270 is a brain-penetrant and highly potent oral SERD that has demonstrated ER degradation and robust antitumor activity across various preclinical models, including those with intracranial xenograft tumors. Methods: This Phase 1 study evaluates the safety, pharmacokinetics and preliminary anti-tumor activity of SIM0270 as monotherapy and/or in combination with palbociclib or everolimus in patients with HR+/HER2- advanced or metastatic breast cancer. The primary

APA, Harvard, Vancouver, ISO, and other styles

27

Kuleshova, Nadezhda E., Alexander V. Vvedenskii, Elena V. Bobrinskaya та Elena В. Rychkova. "Роль структурно-морфологического состояния поверхности платины в кинетических и термодинамических характеристиках процесса адсорбции аниона серина". Kondensirovannye sredy i mezhfaznye granitsy = Condensed Matter and Interphases 21, № 1 (2019): 72–83. http://dx.doi.org/10.17308/kcmf.2019.21/718.

Full text

Abstract:

Исследована адсорбция аниона серина на гладком Pt и Pt(Pt)-электроде. Методом кривых заряжения получены стационарные и кинетические изотермы адсорбции. Установлено, что как на гладком, так и Pt(Pt)-электроде, кинетика исследуемых процессов подчиняется уравнению Рогинского-Зельдовича, а стационарное заполнение описывается изотермой Темкина. При этом адсорбция аниона серина на Pt(Pt) сопровождается диссоциацией адсорбата. Найдены основные термодинамические характеристики (константа адсорбционного и изменение свободной энергии Гиббса) процесса адсорбции аниона серина на обоих электродах. &#

APA, Harvard, Vancouver, ISO, and other styles

28

Warmansyah, Jhoni, Afriyane Ismandela, Dinda Fatma Nabila, et al. "Smartphone Addiction, Executive Function, and Mother-Child Relationships in Early Childhood Emotion Dysregulation." JPUD - Jurnal Pendidikan Usia Dini 17, no. 2 (2023): 241–66. http://dx.doi.org/10.21009/jpud.172.05.

Full text

Abstract:

Early childhood emotional dysregulation is critical in recognizing and preventing psychological well-being disorders, laying the groundwork for developing healthy emotional behaviors early on. This study aims to determine the direct influence of smartphone addiction, executive function, and the mother-child relationship on emotional dysregulation in early childhood in West Sumatra. This research method is a quantitative survey. The data collection technique in this research uses a questionnaire design on 309 parents who were selected using a simple random sampling method. This data processing

APA, Harvard, Vancouver, ISO, and other styles

29

M. Ch., R. "Kodansha Ltd., <em>Kodansha Encyclopedia of Japan</em>, Tokio, 1983. 9 vols. + suplemento." Estudios de Asia y África, September 1, 1990, 575–76. http://dx.doi.org/10.24201/eaa.v25i3.1217.

Full text

Abstract:

Tang Song ci jan shang ci dian [La lírica de las dinastías Tang [618-906] y Song [960-1279] Sluzhou, 1986. 1517 pp. Song shi jian shang ci dian [La poesía de la dinastía Song], Shaghai 1987. 1610 pp. Gu shi jian shang ci dian (La poesía antigua), Pekín, 1988. 1414 pp. Yuan qu jian shang ci dian (La canción de la dinastía Yuan [1279-1368]), Pekín 1988. 1521 pp. R. M. Ch.

APA, Harvard, Vancouver, ISO, and other styles

30

黄, 聖松. "楊伯峻《春秋左傳注》考訂四則——以《左傳》成公二年爲範圍". 人文中國學報, 1 травня 2021, 1–24. http://dx.doi.org/10.24112/sinohumanitas.321990.

Full text

Abstract:

LANGUAGE NOTE | Document text in Chinese; abstract also in English. 本文考訂楊伯峻《春秋左傳注》（以下簡稱《左傳注》），以《左傳》成公二年爲範圍，討論“無能爲役”“詰朝”、“朝食”、“大户”四則。經詞例分析，“無能爲役”之“役”當爲名詞，應從《左傳》襄公十七年《春秋左傳集解》（以下簡稱《集解》）釋爲“役事”，較《左傳注》解作“僕役”適洽。《左傳》四見“詰朝”，《集解》於三處釋“平旦”、一處釋“明朝”，《左傳注》解作明日早晨。本文讀“詰”爲“佶”而訓爲“正”，先秦典籍“正”字常有“平”義；至於“朝”與“旦”皆有“早”義，故“詰朝”即“平旦”。《左傳注》謂“朝食”爲早上進食，《史記》則將“朝食”寫爲“會食”。然就《左傳》載齊頃公“余姑翦滅此而朝食”語，顯是自認可在早上結束戰争，故“朝食”仍應解爲在早上進食。《集解》釋“大户”爲“閲民户口”而《左傳注》解作“清理户口”，“大户”之“大”應讀爲“汏”。《説文》謂“汏”字本義爲“淅㶕”，即後世所謂淘洗，沙汏、淘汏皆自“汏”字本義引申。從另一角度言，“淅㶕”亦有清理、計算義；且《左傳》“閲”字亦有“計算”義，故《集解》釋“大户”爲“閲民户口”即計算户籍，乃讀“大”爲“汏”。 This article examines four phrases in Yang Bojun’s C

APA, Harvard, Vancouver, ISO, and other styles

31

Salehnasab, Behnam, and Sarvnaz Hashem-Sharifi. "Low cycle fatigue behavior and life prediction of a directionally solidified alloy." Journal of Design Against Fatigue 2, no. 1 (2024). http://dx.doi.org/10.62676/ygye8n63.

Full text

Abstract:

Alloys used in engines are subjected to challenging environments characterized by thermal and mechanical cyclic loadings during start-up and shut-down processes. These conditions can significantly increase the occurrence of fatigue failure mechanisms. Therefore, this study focuses on investigating the low cycle fatigue (LCF) behavior of directionally-solidified alloy at two distinct temperatures, namely 600 °C and 800 °C. Strain-controlled LCF tests were conducted at the specified temperatures, utilizing constant total strain amplitudes of 0.4%, 0.6%, 0.8%, and 1% under a totally reversed load

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!